KMG CHEMICALS INC Balance Sheet

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2018 As of Jul 31, 2018	Q3 FY2018 As of Apr 30, 2018	Q2 FY2018 As of Jan 31, 2018	Q1 FY2018 As of Oct 31, 2017	Q4 FY2017 As of Jul 31, 2017	Q3 FY2017 As of Apr 30, 2017	Q2 FY2017 As of Jan 31, 2017	Q1 FY2017 As of Oct 31, 2016	Q4 FY2016 As of Jul 31, 2016	Q3 FY2016 As of Apr 30, 2016	Q2 FY2016 As of Jan 31, 2016	Q1 FY2016 As of Oct 31, 2015	Q4 FY2015 As of Jul 31, 2015	Q3 FY2015 As of Apr 30, 2015	Q2 FY2015 As of Jan 31, 2015	Q1 FY2015 As of Oct 31, 2014	Q4 FY2014 As of Jul 31, 2014	Q3 FY2014 As of Apr 30, 2014	Q2 FY2014 As of Jan 31, 2014	Q1 FY2014 As of Oct 31, 2013
Assets
Current assets
Cash and cash equivalents
Restricted cash
Accounts receivable
Trade, net of allowances of $219 at July 31, 2018 and $263 at July 31, 2017
Other
Inventories, net
Current deferred tax assets
Prepaid expenses and other
Assets held for sale
Total current assets

Property, plant and equipment, net
Deferred tax assets
Goodwill
Intangible assets, net
Restricted cash
Other assets, net
Total assets
Liabilities & stockholders’ equity
Current liabilities
Accounts payable
Accrued liabilities
Employee incentive accrual
Current portion of long-term debt
Total current liabilities
Long-term debt, net
Deferred tax liabilities
Other long-term liabilities
Total liabilities
Stockholders’ equity
Common stock, $.01 par value, 40,000,000 shares authorized, 15,509,733 shares issued and outstanding at July 31, 2018 and 11,889,649 shares issued and outstanding at July 31, 2017
Additional paid-in capital
Accumulated other comprehensive loss
Retained earnings
Total stockholders’ equity
Total liabilities and stockholders’ equity

Comments